Investor Relations
For more information please contact:
Howard Gofstrand                                                                                                 
Tel: (305) 918-7000
Fax: (305) 466-1747
Email: hg@amcapventures.com

Recent Releases
7 May 2008
Generex Study Proposes Increased Reporting of Clinical Outcomes to Support Reimbursement of Non-Injectable Insulin Options

7 Apr 2008
Generex Biotechnology Announces North American Initiation of Generex Oral-lyn Phase III Diabetes Study

Events
6 Nov 2006
Rodman & Renshaw 8th Annual Healthcare Conference

Exchange

NASDAQ Stock Exchange (.O)

Listed Security

GNBT Common Stock

Corporate Counsel
Eckert Seamans Cherin & Mellott, LLC
1515 Market Street, 9th Floor
Philadelphia, PA 19102
Phone 215-851-8447
Fax 215-851-8383

Independent Accountants
BDO Dunwoody LLP
P.O. Box 32, Royal Bank Plaza
Toronto, ON M5J 2J8 CAN
Phone 416-369-6127
Fax 416-865-0887